Gyre Therapeutics, Inc. (GYRE) Gross margin 2022–2025
Gyre Therapeutics, Inc. (GYRE) gross margin by fiscal year — reported gross profit divided by reported revenue.
95.4%FY2025 · since FY2022: 95.3% → 95.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 95.4% | -1.0 pp |
| FY2024 | 96.3% | +0.4 pp |
| FY2023 | 95.9% | +0.6 pp |
| FY2022 | 95.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More GYRE financial trends
GYRE RevenueGYRE Net incomeGYRE Net marginGYRE Gross profitGYRE Operating incomeGYRE Operating marginGYRE Operating cash flowGYRE Free cash flowGYRE Capital expendituresGYRE Return on equityGYRE Stock buybacksGYRE Dividends paidGYRE Total assetsGYRE Total liabilitiesGYRE Shareholders’ equityGYRE overview →